Skip to content
My WebMD Sign In, Sign Up

Multiple Sclerosis Health Center

Font Size

Long-Term Use of MS Drug Seems Safe

Preliminary Results Are in for 16-Year Follow-Up of Betaseron Study

Researchers' Perspective

"While it is premature to draw firm conclusions from preliminary data, I am particularly struck by the mortality trend among patients in the placebo arm appearing to be threefold different than that of patients receiving Betaseron," says researcher Barry Arnason, MD, in a news release.

"The reasons for this difference are unknown right now, but hopefully, we will get a clearer understanding of why this difference occurred when the study is completed and the data analyzed more thoroughly," continues Arnason, who works at the University of Chicago's neurology department.

The full report will include data on functions such as memory, attention, and reasoning, says Ebers.

Side Effects

The follow-up data didn't include side effects. According to Berlex, possible side effects include decrease in infection-fighting white blood cells, injection site reaction, weakness, flu-like symptoms, headache, and pain.

Caution should be used with depressed patients, says Berlex. Also, the drug company recommends rotating the injection sites, noting that injection site necrosis has been reported in 5% of patients in trials.

Women should be warned about potential risks of using the drug while pregnant, and cases of a rare but potentially life-threatening allergic reaction have also been reported, says Berlex.

1|2

Today on WebMD

brain and teriflunomide molecule
ARTICLE
neural fiber
ARTICLE
 
white blood cells
VIDEO
linguini with asparagus and mushrooms
ARTICLE
 
brain scan
ARTICLE
worried woman
ARTICLE
 
person writin in a notebook
ARTICLE
couple embracing
ARTICLE
 
man with cane
SLIDESHOW
skull and neck xray
ARTICLE
 
Stressed man
ARTICLE
doctor feeling patients neck
ASSESSMENT